Skip to content

Study · Not a test of the peptide alone · 2005

1 result

Production of recombinant porcine IGF-binding protein-5 and its effect on proliferation of porcine embryonic myoblast cultures in the presence and absence of IGF-I and Long-R3-IGF-I.

Pampusch MS, Xi G, Kamanga-Sollo E, Loseth KJ, Hathaway MR, Dayton WR, White ME

The Journal of endocrinology1 Apr 2005Cited by 17 (Europe PMC)

PMID15817840 (opens in a new tab)DOI10.1677/joe.1.06037 (opens in a new tab)PepBankPUB-15817840
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking IGF-1 LR3.

  1. 01LabNot a test of IGF-1 LR3 aloneIn vitro (cells)Mechanism

    In porcine embryonic myogenic cells, recombinant porcine IGFBP-5 suppressed Long-R3-IGF-I-stimulated proliferation, which indicates IGF-independent activity of IGFBP-5.

    In plain wordsIn cells, the binding protein IGFBP-5 reduced growth of muscle cells that Long-R3-IGF-I had stimulated. The agent tested was IGFBP-5.

    Peptide
    IGF-1 LR3
    Outcome
    DecreaseLong-R3-IGF-I-stimulated proliferation with rpIGFBP-5
    Study

    pign: not reported in source

    Porcine embryonic myogenic cell (PEMC) cultures
    Outcome group
    Cell proliferation and differentiation · Musculoskeletal

    Source sentences

    Summary
    rpIGFBP-5 also suppressed Long-R3-IGF-I-stimulated proliferation of PEMCs (P>0.05)

    In this study, IGF-1 LR3 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking IGF-1 LR3.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.